ALK-Positive Large B-Cell Lymphoma

specific

A usually aggressive large B-cell lymphoma characterized by the presence of monomorphic immunoblast-like neoplastic B-lymphocytes in a sinusoidal growth pattern. The neoplastic B-lymphocytes express the ALK kinase but they lack the 2;5 translocation.

20

Centers

22

Active Trials

—

Cancer Funding

Top Centers for ALK-Positive Large B-Cell Lymphoma(20)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
Roswell Park Comprehensive Cancer CenterBuffalo, NY
NCI Comprehensive
High-Volume Research Center
72.7
2
The University of Arizona Cancer CenterTucson, AZ
NCI Comprehensive
High-Volume Research Center
72.7
3
Fred Hutch Cancer CenterSeattle, WA
NCI Comprehensive
Active Research Program
50.2
4
Siteman Cancer CenterSt. Louis, MO
NCI Comprehensive
Active Research Program
50.2
5
Mayo Clinic Comprehensive Cancer CenterRochester, MN
NCI Comprehensive
Active Research Program
50.2
6
The University of Texas MD Anderson Cancer CenterHouston, TX
NCI Comprehensive
Active Research Program
50.2
7
Duke Cancer InstituteDurham, NC
NCI Comprehensive
Active Research Program
50.2
8
The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL
NCI Comprehensive
Active Research Program
50.2
9
Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX
NCI Comprehensive
Active Research Program
50.2
10
Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY
NCI Comprehensive
Active Research Program
50.2
11
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH
NCI Comprehensive
Active Research Program
50.2
12
Moffitt Cancer CenterTampa, FL
NCI Comprehensive
Active Research Program
50.2
13
Medical College of Wisconsin Cancer CenterMilwaukee, WI
Active Research Program
50.2
14
The University of Kansas Cancer CenterKansas City, KS
NCI Comprehensive
Active Research Program
50.2
15
Dartmouth Cancer CenterLebanon, NH
NCI Comprehensive
Active Research Program
50.2
16
University of Illinois Cancer CenterChicago, IL
Active Research Program
50.2
17
Boston University Cancer CenterBoston, MA
Active Research Program
50.2
18
Cancer Center at IllinoisUrbana, IL
Active Research Program
50.2
19
Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL
Active Research Program
50.2
20
Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ
Active Research Program
50.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →